NCI, Inc. is a provider of IT service management to U.S. defense, intelligence, health and civilian government agencies.

According to the Complaint, it is alleged that on July 17, 2017, in order to convince NCI shareholders to tender their shares, the Board authorized the filing of a materially incomplete and misleading Schedule 14D-9 Solicitation/Recommendation Statement with the Securities and Exchange Commission. In particular, the Recommendation Statement contains materially incomplete and misleading information concerning: (i) NCI’s financial projections; (ii) the valuation analyses performed by the Company’s financial advisors Wells Fargo & Co. LLC (“Wells Fargo”) and Stifel, Nicolaus & Company, Incorporated; and (iii) potential conflicts of interest Wells Fargo faced as a result of its prior dealings with HIG.

This case was voluntarily dismissed on January 15, 2018.